McKesson looks for $100m synergies with $2.1bn PSS buy
This article was originally published in Clinica
Executive Summary
Pharmaceutical and medical products distributor McKesson has boosted its medtech offering by agreeing to acquire PSS World Medical for $29 per share, or $2.1 billion in total including PSS's outstanding debt. The offer price is a 34% premium over PSS's closing share price of $21.60 on 24 October, the day before the deal was announced.